本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Veru Inc.

0.5677
-0.0022-0.39%
成交量:15.43萬
成交額:8.92萬
市值:8,310.22萬
市盈率:-2.16
高:0.6000
開:0.6000
低:0.5600
收:0.5699
資料載入中...

公司資料

公司名字:
Veru Inc.
交易所:
NASDAQ
成立時間:
1971
員工人數:
210
公司地址:
2916 North Miami Avenue,Suite 1000,Miami,Florida,United States
郵編:
33127
電話:
傳真:
- -
簡介:
Veru Inc.成立於1971年。是一家臨床後期生物製藥公司,專註於開發治療代謝性疾病、腫瘤學、ARDS的新藥。該公司的藥物開發計劃包括兩個晚期新化學實體,enobosarm和sabizabulin。

董事

名稱
職位
Harry Fisch
Director,Vice Chairman of the Board,Chief Corporate Officer
Mitchell S. Steiner
President and Chief Executive Officer and Director,Chairman of the Board
Grace Hyun
Director
Lucy Lu
Director
Mario Eisenberger
Director
Michael L. Rankowitz
Director

股東

名稱
職位
Mitchell S. Steiner
President and Chief Executive Officer and Director,Chairman of the Board
Michele Greco
Chief Financial Officer and Chief Administrative Officer
Harry Fisch
Director,Vice Chairman of the Board,Chief Corporate Officer
K. Gary Barnette
Chief Scientific Officer